Related references
Note: Only part of the references are listed.Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
Georg Petzold et al.
NATURE (2016)
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
Jan Kroenke et al.
NATURE (2015)
Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide
Eric S. Fischer et al.
NATURE (2014)
Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs
Philip P. Chamberlain et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
Yuan Xiao Zhu et al.
BLOOD (2011)
Teratogenic effects of thalidomide: molecular mechanisms
Takumi Ito et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Treatment of multiple myeloma
S. Vincent Rajkumar
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Synthesis and Configurational Stability of (S)- and (R)-Deuteriothalidomides
Takeshi Yamamoto et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2010)
Recent advances of IMiDs in cancer therapy
Shirong Li et al.
CURRENT OPINION IN ONCOLOGY (2010)
Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia
Franck Lebrin et al.
NATURE MEDICINE (2010)
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito et al.
SCIENCE (2010)
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Ian W. Davis et al.
NUCLEIC ACIDS RESEARCH (2007)
Thalidomide induces limb deformities by perturbing the Bmp/Dkk1/Wnt signaling pathway
Juergen Knobloch et al.
FASEB JOURNAL (2007)
Mechanism of auxin perception by the TIR1 ubiquitin ligase
Xu Tan et al.
NATURE (2007)
The thalidomide saga
Magda Melchert et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Protocols for production of selenomethionine-labeled proteins in 2-L polyethylene terephthalate bottles using auto-induction medium
HK Sreenath et al.
PROTEIN EXPRESSION AND PURIFICATION (2005)
Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery
Y Pommier et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Timeline - The evolution of thalidomide and its IMiD derivatives as anticancer agents
JB Bartlett et al.
NATURE REVIEWS CANCER (2004)
Thalidomide pharmacokinetics and metabolite formation in mice, rabbits, and multiple myeloma patients
F Chung et al.
CLINICAL CANCER RESEARCH (2004)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation
JJ Higgins et al.
NEUROLOGY (2004)
Chiral inversion of the second generation IMiD™ CC-4047 (ACTIMID™) in human plasma and phosphate-buffered saline
SK Teo et al.
CHIRALITY (2003)
Misregulation of gene expression in the redox-sensitive NF-κB-dependent limb outgrowth pathway by thalidomide
JM Hansen et al.
DEVELOPMENTAL DYNAMICS (2002)
Share Paper
